Sebastian Finkener
Aarau, AG, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Emerging CSF and Serum Biomarkers in Multiple Sclerosis: Cytokines, MOG, GFAP, and Beyond.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 23, 2026
The Treatment of Antibody-Mediated Encephalitis: Current, Future Therapies, Unmet Need and Patient Management.
Journal: Advances in therapy
Published: November 25, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.
Journal: Clinical chemistry and laboratory medicine
Published: November 08, 2025
Unraveling Microstructural and Macrostructural Brain Age Dynamics in Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 19, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
Journal: Brain : a journal of neurology
Published: June 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.
Journal: Brain : a journal of neurology
Published: June 14, 2025
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort.
Journal: Journal of neurology
Published: May 05, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 29, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.
Journal: Annals of clinical and translational neurology
Published: April 01, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 15, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 15, 2025
Last Updated: 09/26/2026